University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK

dc.contributor.authorVoorham, Jaco
dc.contributor.authorRoche, Nicolas
dc.contributor.authorBenhaddi, Hicham
dc.contributor.authorvan der Tol, Marianka
dc.contributor.authorCarter, Victoria
dc.contributor.authorvan Boven, Job F. M.
dc.contributor.authorBjermer, Leif
dc.contributor.authorMiravitlles, Marc
dc.contributor.authorPrice, David B.
dc.contributor.institutionUniversity of Aberdeen.Institute of Applied Health Sciencesen
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.date.accessioned2018-12-12T05:22:05Z
dc.date.available2018-12-12T05:22:05Z
dc.date.issued2018-10
dc.descriptionAcknowledgements: The authors thank Derek Skinner, Francis Appiagyei and Tanith Hjelmbjerg of the Observational and Pragmatic Research Institute for providing assistance with data analysis. The authors also thank Ian Grieve and Bill Watkins of Ashfield Healthcare Communications, part of UDG Healthcare, for providing medical writing support. The authors thank Teva Pharmaceuticals for providing a full review of the article. Funding: This study was supported by Teva Pharmaceuticals and undertaken by OPRI (http://opri.sg). Medical writing support was funded by Teva Pharmaceuticalsen
dc.description.statusPeer revieweden
dc.format.extent12
dc.format.extent1663478
dc.identifier141027523
dc.identifier914d48e9-75e5-4bac-8fff-895cabfa76ad
dc.identifier30368448
dc.identifier85055659550
dc.identifier.citationVoorham, J, Roche, N, Benhaddi, H, van der Tol, M, Carter, V, van Boven, J F M, Bjermer, L, Miravitlles, M & Price, D B 2018, 'Real-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UK', BMJ Open, vol. 8, no. 10, e022051, pp. 1-12. https://doi.org/10.1136/bmjopen-2018-022051en
dc.identifier.doi10.1136/bmjopen-2018-022051
dc.identifier.iss10en
dc.identifier.issn2044-6055
dc.identifier.urihttp://hdl.handle.net/2164/11604
dc.identifier.vol8en
dc.language.isoeng
dc.relation.ispartofBMJ Openen
dc.subjectR Medicine (General)en
dc.subject.lccR1en
dc.titleReal-world effectiveness evaluation of budesonide/formoterol Spiromax for the management of asthma and chronic obstructive pulmonary disease in the UKen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
e022051.full.pdf
Size:
1.59 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
8.31 KB
Format:
Plain Text
Description: